# Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease

> **NCT06129409** · PHASE1 · COMPLETED · sponsor: **NodThera Limited** · enrollment: 67 (actual)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **DRUG:** NT-0796

## Key facts

- **NCT ID:** NCT06129409
- **Lead sponsor:** NodThera Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-10
- **Primary completion:** 2024-04-15
- **Final completion:** 2024-04-15
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2024-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06129409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06129409, "Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06129409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*